Inhalation

INH0426

Issue link: https://www.e-digitaleditions.com/i/1544305

Contents of this Issue

Navigation

Page 30 of 47

Inhalation April 2026 29 bridge, United Kingdom) and micronized flutica- sone propionate (micFP, Coral Pharma, Mumbai, India). By interpreting both the absorption contrast and phase contrast present in the virtual volume, the excipient lactose has a different grayscale value compared to the micronized material, enabling seg- mentation into the two phases. However, the various micronized materials behave differently, which can be seen in the virtual volumes: LH300 is sparsely dis- tributed throughout the blend, micTBS is shown to collect in aggregates, while micFP adheres to lactose carrier particles, forming layers around the excipient. e micFP blend contains particularly detailed par- ticle structures due to the drug binding tightly with the excipient, and two different structures revealed by XCT are shown in Figures 4A and 4B. For com- parison, SEM imaging of the same blend is shown in Figure 4C. e 3D structures can be probed through XCT, whereas SEM imaging can produce very detailed images but cannot see beyond the surface. is is particularly evident for the agglomerate in the center of Figure 4C, when compared to the agglom- erate shown by XCT in Figure 4B. A further advantage to XCT as a technique is that it allows quantitative analysis. For example, the struc- tures shown in Figure 4 can be quantified using dif- ferent metrics, with the drug-phase thickness for all drug-carrier units (or "clusters") in the micFP blends shown in Figure 5A, highlighting intra- sample vari- ation in the cluster structures. Similarly, metrics can be used for comparisons between samples or between blends, with Figure 5B showing how the three blends highlighted in Figure 3 have different structures. In line with the qualitative observations, micFP forms thicker regions, whereas LH300 is very sparsely distributed. and more coherent X-ray source compared to elec- tron tubes, thereby enabling much faster imaging. e radiographic projections are then mathemati- cally reconstructed to produce a virtual volume rep- resentation of the sample. is virtual volume can be interrogated to provide valuable insight into the sam- ple. For example, early work by Fu and colleagues [14] showed how the virtual volume could reveal the packing of powder beds, which could then be input into discrete element methods (DEM models). e development of X-ray optics [15] has enabled higher resolutions more suitable for inhalation mate- rials. For example, at sub-micron pixel sizes, X-ray computed tomography can reveal subtle differences in the structuring and positions of fine particles between milled and sieved lactose grades (Figures 2A and 2B) [12]. At nanoscale, the virtual volume can give unique insight into single particle structures, such as interior cracks within individual lactose crystals (Fig- ure 2C) or spatial particle size distributions within a micronized lactose agglomerate (Figure 2D) [16]. ese are truly 3D insights, which are not obtainable through the other aforementioned characterization techniques, and also not achievable through other utilization of X-rays, for example, using radiographic projections to measure fill-weights [17]. Revealing formulated structures X-ray computed tomography can uniquely show the formulated structure between an API and excipient lactose [18, 19], as illustrated in Figure 3, which depicts lactose monohydrate (Lactohale ® 100, LH100, DFE Pharma, Goch, Germany) blended with each of the following: micronized lactose (Lac- tohale 300, LH300, DFE Pharma), micronized terbutaline sulphate (micTBS, AstraZeneca, Cam- Figure 1 Summary of attributes of selected existing characterization techniques. The gray bars highlight desired attributes for characterization of pre-actuated formulations. TOF-SIMS TOF-SIMS 20 15 10 5 0 Resolution (µm) Resolution MDRS SEM-EDX Depth Penetration Depth Penetration (µm) 1,000.0 10.0 0.1 MDRS SEM-EDX TOF-SIMS Imaging Field of View Field of View (µm) 1,000 100 10 1 MDRS SEM-EDX Sample Disruption Sample Disruption? Yes No MDRS SEM-EDX TOF-SIMS

Articles in this issue

view archives of Inhalation - INH0426